0001161697-23-000586.txt : 20231207 0001161697-23-000586.hdr.sgml : 20231207 20231207170014 ACCESSION NUMBER: 0001161697-23-000586 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231205 FILED AS OF DATE: 20231207 DATE AS OF CHANGE: 20231207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Steve CENTRAL INDEX KEY: 0001402535 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 231473009 MAIL ADDRESS: STREET 1: 220 MIRACLE MILE STREET 2: SUITE 234 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 12-05-2023 X0508 4 2023-12-05 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001402535 Miller Steve 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Op. & Scientific Officer 0 Common stock, par value $0.001 per share 2023-12-05 4 S 0 40000 14.24 D 647457 D Shares were sold to fund the exercise price and tax withholding associated with the exercise of a stock option that will expire on January 3, 2024 and not as a result of any disagreement with the Company. Represents a weighted average price for the shares sold. Shares were sold in a range from $14.23 to $14.26 per share. /s/ Steve Miller 2023-12-07